4AB:ETR
AbbVie Common Stock
€262.80
arrow_upward
+1.19%(+3.10) 1D
Nov 9, 9:04:31 AM GMT+1 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 4AB...
Open
€262.80
High
€262.80
Low
€262.80
Mkt. cap
514.92B
Avg. vol.
912.00
Volume
48.00
52-wk high
€270.70
52-wk low
€162.85
No. of employees
57K
Open
€262.80
High
€262.80
Low
€262.80
Mkt. cap
514.92B
Avg. vol.
912.00
Volume
48.00
52-wk high
€270.70
52-wk low
€162.85
No. of employees
57K
News stories
From web sources and news partners
BioSpace
·
4 hours ago
With an approval apiece, the verdict is still out on AbbVie’s and BMS’ twin neuro buys
Oxford Mail
·
4 hours ago
Pharmaceutical giant opens £120m research centre in Oxford
Yahoo Finance
·
17 hours ago
Is AbbVie Inc. (ABBV) the Best Healthcare Stock to Buy Following the 2026 Democratic Midterm Sweep?
Trefis
·
2 days ago
What Could Stall AbbVie Stock’s Run?
Profile
AbbVie Inc., also known as AbbVie, is an American pharmaceutical company headquartered in North Chicago, Illinois. AbbVie produces drugs to treat a wide range of medical issues.
The company is ranked sixth on the list of largest biomedical companies by revenue. It is ranked 77th on the Fortune 500 and 108th on the Forbes Global 2000. The name "AbbVie" is derived from a combination of "Abbott", the name of its former parent company, with "vie", intended as a reference to a Latin root meaning 'life'. Wikipedia
About AbbVie Common Stock
CEORobert A. Michael
Employees57K
FoundedApr 10, 2012
HeadquartersNorth Chicago, Illinois, United States
SectorHealth Care
IndustryBiotechnology
Websiteabbvie.com